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Summary
An important direction in chemical biology is the
derivation of compounds that affect cellular differenti-
ation or its reversal. The fragmentation of multinucle-
ate myofibers into viable mononucleates (called
cellularization) occurs during limb regeneration in
urodele amphibians, and the isolation of myoseverin,
a trisubstituted purine that could apparently activate
this pathway of myogenic dedifferentiation in mam-
malian cells, generated considerable interest. We
have explored the mechanism and outcome of cellula-
rization at a single-cell level, and we report findings
that significantly extend the previous work with
myoseverin. Using a panel of compounds, including
a triazine compound with structural similarity and
comparable activity to myoseverin, we have identified
microtubule disruption as critical for activation of the
response. Time-lapse microscopy has enabled us to
analyze the fate of identified mononucleate progeny,
and directly assess the extent of dedifferentiation.
Introduction
The most extensive regenerative ability in adult verte-
brates is found among the various species of salaman-
der, urodele amphibians that retain the tail after
metamorphosis. These animals are the only vertebrates
able to regenerate the limb, and this proceeds by forma-
tion of a blastema, a growth zone of mesenchymal stem
cells at the end of the stump [1]. Regeneration in sala-
manders depends on the plasticity of differentiated cells
at the site of tissue injury or removal, and one process
implicated in the formation of the blastema is that of
cellularization, the fragmentation of multinucleated myo-
fibers into mononucleate cells that divide and contrib-
ute to the regenerate [2]. Cellularization has been
studied in salamanders both by implantation of labeled
myotubes into the limb blastema [3, 4] and by direct ob-
servation of microinjected myofibers in the context of
the regenerating tail [5]. The cellular and molecular
mechanisms underlying cellularization are unclear, and
the discovery of a small molecule that could induce
*Correspondence: j.brockes@ucl.ac.ukthis process in mammalian myotubes was therefore
a significant step forward. The purine derivative 1 (Fig-
ure 1A), named myoseverin, was identified after screen-
ing a combinatorial library [6], and there is currently
considerable interest in finding compounds that can
induce cellular differentiation or its reversal, with atten-
dant implications for regenerative biology and medicine
[7–11].
Myoseverin is a molecule that binds to and depoly-
merizes microtubules, but several established depoly-
merizing agents were found not to induce reversible
cellularization of mouse C2C12 myotubes in the manner
of myoseverin [6, 12]. Following cellularization, an ap-
parent increase in cell division could be observed in
the cultures, and this suggested that the mononucleate
progeny were able to return to the cell cycle, a further
step in the reversal of myogenic differentiation. In addi-
tion to the morphological changes brought about in re-
sponse to myoseverin, the authors reported a second
aspect of its action. The cellularization events reminis-
cent of urodele regeneration were complemented by
a transcriptional program indicative of tissue regenera-
tion and wound healing. A microarray analysis revealed
that over half of the genes whose expression was al-
tered significantly by myoseverin were deemed to be in-
volved in processes suggestive of a tissue response to
injury, such as remodeling of the extracellular matrix, in-
flammation, and coagulation [6].
In this paper, we have reinvestigated the mechanism
of cellularization in mammalian myotubes first by using
a panel of compounds that induce this effect, second by
introducing methods that follow the process in real time
in single myotubes, and third by relating cellularization
to other aspects of phenotypic dedifferentiation. Our re-
sults indicate a significant reappraisal of the activity of
these compounds.
Results
A Triazine Compound Can Induce Cellularization
of Mammalian Myotubes
In addition to myoseverin, our investigation included
a second set of compounds, structurally related to my-
oseverin but based around a triazine scaffold [13–15].
We compared the effect of these compounds on differ-
entiated cultures of pmi28 cells, a murine myoblast cell
line in which cells typically fuse to form elongated, multi-
nucleate myotubes [16, 17] that are more responsive to
cellularizing agents than C2C12 cells. A cellular assay
based on detection of myosin heavy chain (MHC), a
late marker of myogenic differentiation, was established
to quantitate the ability of these compounds to induce
myotube fragmentation. MHC is expressed only in dif-
ferentiated muscle after postmitotic arrest and fusion,
and it remained detectable by immunocytochemistry
for 24 hr in myotube fragments generated by the action
of myoseverin (Figure 1B). The number of MHC-positive
mononucleates, expressed as the percentage of all
mononucleates, was used as an index of myotube frag-
mentation. The triazine 2 (Figure 1A) had the same
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1118Figure 1. Myoseverin and Other Microtubule Binding Molecules Induce the Reversible Fragmentation of Mammalian Myotubes
(A) Structures of myoseverin, 1, the structurally related triazine compounds, 2 and 3, and the known microtubule-depolymerizing agent noco-
dazole, 4. Details of the synthesis of 2 and 3 will be published elsewhere.
(B) pmi28 myotube cultures were treated for 24 hr with a range of compounds and then stained with an antibody against MHC (green), and the
nuclei were counterstained with propidium iodide (red). Compound 2 affects myotubes in the same way as myoseverin, causing the cells to
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1119Figure 2. Compound 2 and Nocodazole Disrupt the Microtubule Cytoskeleton
Immunofluorescence images of b-tubulin in myoblasts treated with differentiation medium alone (Control), the inactive triazine compound 3,
compound 2, or nocodazole for 24 hr. No effect on microtubule organization is seen in the presence of compound 3, but at concentrations
sufficient to induce cellularization of myotubes, compound 2 and nocodazole have analogous effects on polymerized tubulin, causing micro-
tubules to become broken and fragmented. The scale bar is 10 mm.ability as myoseverin to fragment mammalian myotubes
in culture (Figure 1B); there was an average 5.2-fold in-
crease in MHC-positive mononucleates (18,000 cells;
n 5 4), a number comparable to that seen with myose-
verin. In contrast, compound 3 (Figure 1A) did not in-
duce a measurable response, and cultures retained
the appearance of control, untreated cells (Figure 1B).
As a structural isomer of 2, the inactive triazine 3 is an
ideal control compound.
Microtubule Disruption Can Induce Cellularization
While microtubules are the only known target of myose-
verin, the specific role of the cytoskeleton in cellulariza-
tion has not been examined in detail. We compared the
effect of myoseverin and compound 2 with that of noco-
dazole (4, Figure 1A), the known microtubule binding
agent and structurally distinct molecule, in order to
determine the significance of microtubule disruption in
cellularization. The effect of nocodazole at 1–10 mM
was previously reported as both toxic and irreversible
[6, 12]; we found that 0.5 mM nocodazole was able to
mimic the action of myoseverin without toxicity, induc-
ing an average 4.5-fold increase in the proportion of
MHC-positive mononucleates (12,000 cells; n 5 3). In
addition, the effects of both 2 and nocodazole were
shown to be readily reversible (Figure 1C), as hadbeen previously demonstrated for myoseverin [6].
When the compounds were removed and replaced
with fresh differentiation medium, MHC-positive mono-
nucleates returned to levels comparable to control cul-
tures. This suggests that the mononucleates arising by
cellularization were competent to fuse again to form my-
otubes under differentiation conditions. The reversible
fragmentation of myotubes by compound 2 is shown
in Movies S1 and S2 (see the Supplemental Data avail-
able with this article online).
Observation of the effects of compound 2 and noco-
dazole on the microtubule cytoskeleton also revealed
analogous results for the two molecules. At concentra-
tions sufficient to induce cellularization of myotubes,
both compound 2 and nocodazole disrupted microtu-
bule organization and polymerization, as reported pre-
viously for myoseverin and shown in Figure 2. The
inactive triazine compound 3 retained an intact microtu-
bule cytoskeleton comparable with that of untreated
cells (Figure 2).
Imaging Cellularization of Single Myotubes
Previous work describing the cellularization of mamma-
lian myotubes by myoseverin has been unable to di-
rectly demonstrate the events of cellularization since
the high density within differentiated cultures hasfragment and round up, generating mononucleates and multinucleate fragments. Compound 3 is inactive, and the cells retain the appearance
of an untreated culture in which myotubes tend to align with one another, with nuclei distributed along the length. Compound 4, nocodazole, is
able to mimic the effects of myoseverin.
(C) The effects of nocodazole and compound 2 are reversible. Panels on the left show myotubes treated for 24 hr with compound 2 or noco-
dazole. The right-hand panels show fusion and restoration of cell morphology after removal of the compounds and incubation in fresh differ-
entiation medium (DM) for an additional 24 hr. Scale bars are 50 mm.
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1120Figure 3. Demonstration of Cellularization of Mammalian Myotubes at a Single-Cell Level
(A and B) Selected frames from time-lapse sequences show the fragmentation of single myotubes over time in response to (A) 15 mM com-
pound 2 and (B) 0.5 mM nocodazole. Cells were differentiated and purified to give isolated myotubes, and these cells were then imaged by
time-lapse microscopy with phase contrast images captured at 5 min intervals. In each case, the resulting mononucleate cell with a single
nucleus is highlighted by a red arrow in the final panel. Cells in (A) were previously transfected with a nuclear-localized eGFP, and fluorescent
images are shown overlaid with phase contrast.made it difficult to visualize individual cells. In order to
study more clearly the morphological changes during
cellularization, we used pmi28 cells stably expressing
a fusion protein of human histone 2B and eGFP [18],
which provided a convenient marker in the nucleus.
The purification of differentiated cultures enabled us
to isolate individual labeled myotubes and to follow their
response to compound 2 by time-lapse microscopy. An
example of a single labeled myotube undergoing cellu-
larization is shown in Figure 3A and in Movie S3. Com-
pound 2 is seen to induce cytoplasmic constrictions in
the myotube on either side of a single nucleus. This is
followed by severing of the cytoplasmic bridges con-
necting the emerging mononucleate to the myotube
fragments. Cellularization of a single myotube by noco-
dazole is shown in Figure 3B and in Movie S4; the
response is striking in its similarity to the action of com-
pound 2 (Figure 3A). These images of cellularization are
indicative of extensive reorganization of the cytoskele-
ton, and the comparable effects of nocodazole and
compound 2 at this level suggest that microtubule de-
polymerization plays a critical role in this aspect of myo-
genic dedifferentiation.Gene Transcription during Cellularization
We analyzed cellularization in the absence of de novo
protein synthesis in order to assess the likely contribu-
tion of a transcriptional program in the response of my-
otubes to the triazine compound 2. Inhibition of protein
synthesis within myotubes to a level of 95% was
achieved with 10 mM anisomycin, while cellularization
with compound 2 was inhibited only by 57% (data not
shown). Although the inhibition of protein synthesis in
these experiments was less than 100%, the induction
of significant levels of cellularization within 24 hr sug-
gested that gene transcription might not be obligatory.
The finding that nocodazole can also bring about the
reversible fission of mammalian myotubes has allowed
us to investigate further the mechanism of cellulariza-
tion by microarray analysis. The use of nocodazole to
dissect the genes regulated by compound 2 enabled
us to assess whether, in addition to its effects on micro-
tubules, compound 2 may also be activating a specific
pattern of gene expression. The number of genes al-
tered by at least 1.5-fold with either compound 2 or no-
codazole over a 24 hr period is shown in Figure 4A. The
inactive isomer 3 was used as a control. Of specific
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1121Figure 4. Gene Expression Analysis of Cellu-
larization by Nocodazole and Compound 2
(A) Summary of genes altered greater than
1.5-fold with either compound 2, nocoda-
zole, or the inactive compound 3. Note that
2 and nocodazole are active but structurally
unrelated, whereas 3 is an inactive isomer
of 2.
(B) List of 20 genes regulated in response to
both compound 2 and nocodazole.interest are the 20 genes, shown in Figure 4A and listed
in Figure 4B, that are regulated by compound 2 and no-
codazole, structurally distinct molecules with the same
activity of myogenic dedifferentiation. This list com-
prises genes covering a wide range of functions and in-
cludes the downregulation of a- and b-tubulin.
Time-Lapse Observations of Mononucleate
Progeny
Reversal of the mononucleate-to-multinucleate transi-
tion is a significant and necessary step in myogenic de-
differentiation. In order to determine if this event was
accompanied by a complete reversal of myogenesis re-
sulting in proliferating mononucleate cells, as was orig-
inally suggested based on observations of dense and
heterogeneous cultures [6], we again used time-lapse
microscopy to follow individual mononucleates arising
by cellularization of single myotubes in response to
compound 2. The use of a motorized stage enableda higher-throughput approach, with the successive
capture of images from up to 20 predetermined fields
at each chosen time point for the duration of the exper-
iment, and the assembly of 20 near-simultaneous mov-
ies from a single culture (Figure 5A). The cells were
maintained in growth medium for up to 4 days after
cellularization and washing to remove the compound.
Under these conditions, preexisting mononucleate myo-
blasts in the culture were seen to proliferate, confirming
that culture conditions were sufficient to induce divi-
sion. In the majority of cases, the cells arising as the
result of a cellularization event survived as mononu-
cleates and regained the elongated morphology char-
acteristic of larger multinucleate myotubes. A total of
115 movies from 13 independent experiments were as-
sembled and analyzed, and no cases of division were
observed in the population of 146 mononucleates
formed by cellularization with compound 2 (summarized
in Figure 5B). In addition, identified mononucleate
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1122Figure 5. Determination of Cell Fate of Mononucleate Progeny
(A) Schematic of a time-lapse experiment to follow the behavior of individual mononucleates, generated by the cellularization of myotubes.
Following purification, isolated myotubes were monitored over a 24 hr period of exposure to compound 2. In conjunction with a motorized
stage, time-lapse microscopy enabled the observation of multiple cellularization events in parallel. The resulting mononucleate progeny were
then followed for an additional 4 days in growth medium before fixation.
(B) Summary of characterization of mononucleate cells (monos) followed by time-lapse microscopy. Of 146 cells (34 followed for 3 days, and
the remaining 112 followed for 5 days) arising by cellularization with compound 2, no cells were observed to undergo cell division. The same
was true of 35 mononucleate cells arising by fragmentation of myotubes by myoseverin. All cells analyzed retained expression of MHC after 5
days in culture, while only a single mononucleate was positive for the presence of centrioles.
(C) Detection of centrioles in multinucleate myotubes by immunocytochemistry. The left panel is a phase contrast image of an isolated my-
otube; nuclei were stained with hoechst (overlaid in blue). The scale bar is 20 mm. The remaining two panels represent a magnified view of
the marked region on the phase contrast image: the central panel shows g-tubulin staining, and the right panel shows pericentrin staining.
g-tubulin localizes to discrete points in the cytoplasm, the centrioles, while pericentrin also localizes to the centrioles but forms a diffuse cloud
of pericentriolar satellites. Pericentrin is also redistributed to the nuclear surface in myotubes.progeny arising by fragmentation of myotubes by myo-
severin were also examined. Again, no cases of cell di-
vision were observed in the 35 mononucleates followed
(in 2 independent experiments) (Figure 5B). This finding
contrasts with that of earlier work with myoseverin in
which cell division was reported [6, 12].
Cells Retain Properties of Parental Myotubes
In a number of cases, cells were fixed at the end of the
time-lapse experiment and were stained for MHC, a
marker of terminally differentiated myotubes. All mono-
nucleate progeny analyzed were found to retain strong
expression of the protein (Figure 5B). MHC-positive
mononucleates were also analyzed for incorporation
of BrdU (bromodeoxyuridine) after fragmentation of pu-
rified myotube cultures with compound 2, followed by
washing of the cells and incubation for a 24 hr period
in growth medium in the presence of BrdU. The results
did not differ significantly between control untreated
cultures in which an average of 2.6% of the MHC-
positive mononucleates incorporated BrdU and cul-
tures treated with compound 2 in which 1.3% of the
cells staining positive for MHC were also positive forincorporation of BrdU (in four independent experi-
ments). This is consistent with the absence of division
reported above.
In addition to MHC, identified mononucleates fixed at
the conclusion of time-lapse experiments were stained
for markers of centrioles. Centrosomes act as the pri-
mary microtubule organizing center (MTOC) of almost
all mammalian somatic cell types. They comprise a
pair of centrioles and a surrounding matrix, the pericen-
triolar material (PCM), from which microtubules are
nucleated and anchored [19]. The centrioles replicate
once every cell cycle, maintaining a 2:1 ratio with the
nucleus, and, in addition to their role in microtubule
organization, they have been shown to be required for
cell cycle progression [20–22]. The progressive loss of
centrioles from muscle cells after differentiation has
been well documented [23–26], and, if they remain
absent from the mononucleates generated by cellulari-
zation of myotubes, then this may contribute to the ob-
served failure to undergo cell division. Pericentrin and
g-tubulin are both well-characterized components of
the PCM [27, 28], and antibodies to these proteins were
used here to detect centrioles in myotubes and in the
Cellularization of Mammalian Myotubes
1123Figure 6. Schematic Diagram of Myogenic
Dedifferentiation
A number of different aspects of myogenesis
must be reversed in order to generate prolif-
erating mononucleate cells from multinucle-
ate, postmitotic myotubes. Cellularization is
an essential process during myogenic dedif-
ferentiation and can be induced by myose-
verin, but it is not sufficient to activate the
full program of dedifferentiation.mononucleate progeny generated from them by the ac-
tion of compound 2. A reduced number of centrioles
was observed in myotubes, and they were no longer as-
sociated in pairs, but were instead seen as isolated foci
or sometimes as clusters (Figure 5C). In all but one of
the mononucleate cells followed by time-lapse micros-
copy and stained for pericentrin and g-tubulin, no cen-
trioles were detected (Figure 5B). All cells stained for
pericentrin displayed circumnuclear localization of the
protein, a distribution pattern associated with terminally
differentiated myotubes [24, 26], as shown in Figure 5C.
Discussion
Our results with a panel of small molecules have defined
a specific role for cellularization within the myogenic de-
differentiation program, and they significantly extend
the conclusions drawn previously with myoseverin. We
report the discovery of a triazine compound 2, with
structural similarity to myoseverin, which is able to bring
about the fragmentation of mammalian myotubes in cul-
ture. Compound 3, a structural isomer of compound 2,
but inactive in our assay for cellularization, provides
an ideal control for experiments with compound 2 to in-
vestigate the mechanism of cellularization in pmi28
cells. The pmi28 cell line [16, 17] was found to be more
stable in culture and more responsive to cellularization
with both myoseverin and compound 2 when compared
with the C2C12 cell line, possibly as a result of the higher
proportion of long, narrow, and unbranched myotubes,
a morphology previously reported to favor cellulariza-
tion [6]. The convergence of forward and reverse activi-
ties with nocodazole indicates that myoseverin brings
about myotube fragmentation primarily through its ef-
fects on microtubules, and has confirmed microtubules
as the critical target of myoseverin [6] and also of the re-
lated triazine compound 2.
The use of nocodazole and compound 2 to examine
the gene expression changes that are specific to cellu-
larization has extended the earlier microarray analysis
carried out with myoseverin alone. We observed the
downregulation of both a- and b-tubulin, but we didnot detect an abundance of transcripts involved in tis-
sue repair and the response to injury as originally
described for myoseverin [6]. It should be noted,
however, that our microarray experiments did not at-
tempt a direct comparison between myoseverin and
compound 2, and it remains possible that, despite
a common action on the microtubule cytoskeleton,
structural differences between myoseverin and com-
pound 2 may enable myoseverin to bind to additional
targets within the cell that are not available to the larger
triazine compound. We also note that the use of the
pmi28 cell line in these experiments and the C2C12
cell line in the earlier work with myoseverin is an addi-
tional consideration. The microarray data presented
here are consistent with the hypothesis that the cellula-
rization of myotubes by compound 2 is brought about
through effects on the microtubule cytoskeleton rather
than by the activation of a program such as that in-
volved in the response of fibroblasts to serum [29], or
during urodele regeneration [2].
The reversal of the mononucleate-to-multinucleate
transition is an essential step in the dedifferentiation
program, and Figure 6 summarizes the different aspects
of myogenic dedifferentiation, including cellularization,
that are required to generate proliferating multipotent,
mononucleate cells from terminally differentiated myo-
tubes. Our experiments have addressed each of these
aspects in response to our panel of small molecules.
Analysis at the single-cell level has confirmed that myo-
severin is able to generate mononucleate progeny from
multinucleate myotubes, but time-lapse microscopy
shows that these cells retain key properties of the
parental myotubes, including expression of MHC and
the postmitotic arrest. The application of time-lapse mi-
croscopy in our experiments has enabled the unambig-
uous identification of individual mononucleate progeny
in the presence of contaminating preexisting myoblasts,
and it is a significant improvement in methodology for
determining cell fate and behavior in the context of
mixed cultures. Using this technology, we did not ob-
serve division of mononucleate progeny, and one as-
pect of this inability to divide may be the absence of
Chemistry & Biology
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that myoseverin is able to bring about cellularization
by acting directly on the microtubule cytoskeleton with-
out activating other elements of the dedifferentiation
program.
Microtubules take part in many vital processes within
the cell, and changes in microtubule dynamics play
an important role in bringing about morphological
changes. During myogenesis, the rearrangement of mi-
crotubules from a radial to a linear array is instrumental
in the elongation and alignment of myoblasts prior to fu-
sion. While the microtubule cytoskeleton participates in
establishing the differentiated state, it seems unlikely
that its integrity is solely responsible for maintaining it,
as supported by our findings that microtubule disrup-
tion is unable to activate a full program of myogenic
dedifferentiation. Studies of cellularization in other sys-
tems, such as Drosophila, in which the formation of sin-
gle cells from a multicellular syncytium occurs during
normal embryonic development, have yet to establish
the role of microtubules in this context, and it remains
to be seen whether there are mechanistic links with uro-
dele regeneration [30, 31].
While it remains possible that extracts of the newt
limb blastema, which have been reported to induce cel-
lularization of mammalian myotubes in culture [32], may
contain myoseverin-like molecules that act directly on
microtubules, it appears more likely that the different
aspects of dedifferentiation (Figure 6) are controlled
by an upstream regulator such as the homeodomain
protein Msx-1. Evidence from both urodele and mam-
malian systems has implicated Msx-1 in the events of
muscle dedifferentiation [33, 34]. Reversal of the mono-
nucleate-to-multinucleate transition is an important and
necessary aspect of myogenic dedifferentiation and is
dependent on dramatic cytoskeletal rearrangements;
we have shown, however, that this is not sufficient to
activate the more complete reversal of the myogenic
program seen during limb regeneration.
Significance
There is currently significant interest in mechanisms
of dedifferentiation and their relevance for regenera-
tive medicine, and an important direction is the
identification of compounds that induce cellular differ-
entiation or its reversal. The work described here dem-
onstrates the value of using small molecules in the
dissection of complex biological processes such as
myogenic dedifferentiation.We have usedmyoseverin
and the triazine compound 2 to analyze the role of one
aspect of myogenic dedifferentiation in the context
of a more complete program. The use of time-lapse
microscopy to carry out an extensive analysis of
the consequences of cellularization for identified
mononucleate cells has enabled us to revise the
current view of myoseverin and describe a role for
cellularization as necessary, but not sufficient, to
induce a full program of myogenic dedifferentiation.
The complete reversal of myogenesis is likely to
require regulatory elements, such as Msx-1, function-
ing upstream of cellularization. While the exact mech-
anism of cellularization awaits further clarification, the
disruption of microtubules is clearly a critical event.Experimental Procedures
Cell Culture
Pmi28 cells were kindly provided by Prof. Anna Starzinski-Powitz
and were grown on BIOCOAT collagen I T-75 flasks (Beckton-
Dickinson) as described [16]. Cells were transfected with a pseudo-
typed retroviral vector encoding an H2B-eGFP fusion protein as
previously described [35]. Pmi28 cultures were allowed to differen-
tiate for 3 days before being trypsinized and purified. The cell sus-
pension was passed first through a 25 mm filter (VWR), and cells
retained on the filter were resuspended in differentiation medium,
then passed through a 100 mm filter (VWR). Cells in the flow-through
were plated onto collagen-coated plastic dishes. BrdU was added
to culture medium at a final concentration of 10 mM for 24 hr, fol-
lowed by extensive washing. Incorporation into cells was detected
by immunocytochemistry.
Cellularization Assay
Cells were plated at high density on silane-coated glass coverslips
and were differentiated for 3 days in pmi28 differentiation medium
before addition of compounds. Myoseverin was used at 25 mM,
and the triazine compounds 2 and 3 were used at 15 mM; nocoda-
zole (Calbiochem) was used at 500 nM. All compounds were diluted
in differentiation medium. For each independent experiment, dupli-
cate coverslips were used for every treatment. After treatment, all
cells were fixed and stained with an antibody against MHC; nuclei
were counterstained with propidium iodide.
Immunocytochemistry
For detection of MHC, cells were fixed in 2% paraformaldehyde
(PFA), followed by postfixation with cold 100% methanol. Cells
were incubated with a monoclonal antibody to mouse MHC
(A4.1025, Dr. Simon Hughes, Randall Institute, Kings College,
London) for 1 hr, followed by incubation with FITC-conjugated rab-
bit anti-mouse (Dako) for 1 hr. For detection of BrdU, cells were
fixed as for MHC staining, which was followed by the addition of
0.5 M hydrochloric acid. Cells were incubated with a mouse mono-
clonal antibody to BrdU (Amersham) overnight at 4ºC, followed
by incubation with Texas Red-conjugated goat anti-mouse IgG1
(Southern Biotechnology Associates, Inc.) for 1 hr. For detection
of centrioles, cells were washed briefly in extraction buffer (EB; 60
mM PIPES [pH 6.9], 25 mM HEPES [pH 6.9], 10 mM EGTA, 1 mM
MgCl2), then fixed on ice in 4% PFA in EB for 10 min. Cells were
then washed in EB 1 0.2% Triton X-100 and were postfixed in
cold 100% methanol. The cells were incubated with the two primary
antibodies against pericentrin (rabbit antibody; Covance) and
g-tubulin (clone GTU-88, mouse monoclonal IgG1 isotype; Sigma),
simultaneously, overnight at 4ºC, followed by incubation with
FITC-conjugated swine anti-rabbit for 1 hr (Dako) and then Texas
Red-conjugated goat anti-mouse IgG1 (Southern Biotechnology
Associates, Inc.) for 1 hr. For microtubule staining, cells were fixed
in 100% cold methanol and incubated overnight with antibody
against b-tubulin (clone TUB 2.1; Sigma). All antibody incubations
and washes were carried out in D-PBS containing 10% goat serum
(Sigma) and 0.05% sodium azide. Nuclei of fixed cells were stained
with either Hoechst 33258 or propidium iodide at 1 mg/ml. The cells
were observed on a Zeiss Axioplan 2 microscope, and phase con-
trast or fluorescent images were captured with an Axiocam HRc dig-
ital camera (Zeiss), controlled through the Axiovision 3.1 software.
Fluorescent images of centrioles and of microtubules were acquired
at 0.2 mm intervals, and deconvolution was applied to the z-stacks
with Volocity and Openlab software (Improvision).
Microarray
Triplicate cultures of differentiated pmi28 cells were prepared for
time zero, for 12 and 24 hr treatments with 15 mM compound 2,
and for 12 and 24 hr treatments with 500 nM nocodazole; duplicate
cultures were prepared for 24 hr treatment with 15 mM compound 3.
Each individual culture gave rise to material for hybridization to a sin-
gle Affymetrix GeneChip; all replicates were treated as independent
samples. Total RNA was extracted by using Tri reagent (Sigma);
cDNA synthesis and in vitro transcription was carried out according
to the Affymetrix Expression Analysis Technical Manual and the
manufacturer’s instructions. For each independent sample, 15 mg
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U74Av2 chip containing 12,488 probe sets. Hybridization was car-
ried out at 45ºC for 16 hr. The GeneChip Fluidics Station 400 was
used to wash and stain the probe array. The antibody amplification
protocol was followed according to the Affymetrix manual. During
the course of sample preparation, RNA degradation and contamina-
tion was checked periodically by gel electrophoresis, spectropho-
tometry, and an Agilent bioanalyzer. At all stages, RNA was of
high quality and was within Affymetrix recommended parameters.
Initial processing of the raw data files for each chip was carried
out by implementation of a number of statistical algorithms in the
Affymetrix Microarray Suite 5.0. A detection call of Present, Mar-
ginal, or Absent was assigned to each probe set, and a signal was
calculated to provide a measure of the abundance of the transcript.
GeneSpring was used to compare the transcription profiles of the
individual array and calculate expression ratios; values less than
1.5-fold were considered unchanged. Affymetrix-supplied gene
names were updated by crossreferencing with GenBank accession
numbers, and where more than one name existed, the most com-
mon or most descriptive was applied.
Time-Lapse Microscopy
Cells in a 35 mm culture dish was placed under an Axiovert S100
(Zeiss) inverted microscope fitted with an incubation chamber to
provide a controlled environment. The microscope was equipped
with a motorized stage and focus (Prior Scientific), controlled
through Image Pro Plus software and an AFA module (Media Cyber-
netics). Phase contrast or fluorescence images were sequentially
acquired through an FDI (Photonic Sciences) or Hamamatsu Orca
ER Camera integrated with the imaging system. The culture dish un-
der study was secured on a dish holder on the stage and covered
with a heated quartz glass lid that allowed for long-term imaging
without any condensation. Humidified 5% CO2 was supplied to
the chamber through a flex pipe. The cells were treated for 24 hr
with cellularizing agents, and images were captured at each prede-
fined stage position and focus plane on the dish every 4–5 min
through a 103 objective. After 24 hr of treatment, the medium was
removed; cells were washed and replaced with growth medium.
Thereafter, time-lapse imaging was continued at the same positions
and focus plane for 4 days at 20 min intervals. Image sequences
were created from each stage position and were analyzed in Image
Pro Plus. The image frames from the sequence of interest were
archived and further processed in Adobe Photoshop 7.0 and Adobe
Illustrator CS.
Supplemental Data
Supplemental Data including movie sequences of myotubes under-
going cellularization in response to compounds are available at
http://www.chembiol.com/cgi/content/full/12/10/1117/DC1/.
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